Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial)Andreas Dietz, Michael Flentje, Florian Hoppe et al.|European Archives of Oto-Rhino-Laryngology|2008Cited by 53
Concomitant hyperfractionated accelerated radiotherapy (HART) with cisplatin and concurrent cetuximab for locoregionally advanced squamous cell head and neck cancer: a phase I dose escalation trialThomas Kuhnt, Juergen Dunst, Alexandra Sandner et al.|Journal of Clinical Oncology|2008Cited by 6